Search research articles
Contact Us
Filters
Showing results (31-40 of 224) with videos related to
Page
of 23
Sort By:
Leukemia & Lymphoma
|
August 19, 2024
Successful treatment of acquired von Willebrand syndrome secondary to low-grade CLL with rituximab and venetoclax
Aaron Boothby, Livia Hegerova, Shelley N Fletcher, et al.
Cancer Cell
|
July 9, 2021
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
Joshua A Hill, Chaitra S Ujjani, Alexander L Greninger, et al.
World Journal of Gastroenterology
|
May 20, 2009
Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk
Mazyar Shadman, Polly A Newcomb, John M Hampton, et al.
Blood Cancer Journal
|
December 4, 2025
Real-world treatment patterns and clinical outcomes among patients with diffuse large B-cell lymphoma in a US healthcare claims database
Mazyar Shadman, Jennifer S Harper, Alex Bokun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte)
Elise A Chong, Lindsey E Roeker, Mazyar Shadman, et al.
British Journal of Haematology
|
July 25, 2024
Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia
Nilanjan Ghosh, Beenish S Manzoor, Bita Fakhri, et al.
Journal of Medical Economics
|
January 19, 2026
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression
Mazyar Shadman, Walter Bouwmeester, Leyla Mohseninejad, et al.
JAMA Oncology
|
February 26, 2026
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial
Mazyar Shadman, Michael LeBlanc, Lisa Rimsza, et al.
Hemasphere
|
December 26, 2022
COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Mazyar Shadman, Catherine Liu, Katherine Eakle, et al.
Leukemia & Lymphoma
|
July 26, 2016
Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience
Mazyar Shadman, Sangeeta Hingorani, Scott A Lanum, et al.
Page
of 23
Search research articles
Search
Showing results (31-40 of 224) with videos related to
Sort By:
Page
of 23
Leukemia & Lymphoma
|
August 19, 2024
Successful treatment of acquired von Willebrand syndrome secondary to low-grade CLL with rituximab and venetoclax
Aaron Boothby, Livia Hegerova, Shelley N Fletcher, et al.
Cancer Cell
|
July 9, 2021
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
Joshua A Hill, Chaitra S Ujjani, Alexander L Greninger, et al.
World Journal of Gastroenterology
|
May 20, 2009
Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk
Mazyar Shadman, Polly A Newcomb, John M Hampton, et al.
Blood Cancer Journal
|
December 4, 2025
Real-world treatment patterns and clinical outcomes among patients with diffuse large B-cell lymphoma in a US healthcare claims database
Mazyar Shadman, Jennifer S Harper, Alex Bokun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte)
Elise A Chong, Lindsey E Roeker, Mazyar Shadman, et al.
British Journal of Haematology
|
July 25, 2024
Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia
Nilanjan Ghosh, Beenish S Manzoor, Bita Fakhri, et al.
Journal of Medical Economics
|
January 19, 2026
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression
Mazyar Shadman, Walter Bouwmeester, Leyla Mohseninejad, et al.
JAMA Oncology
|
February 26, 2026
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial
Mazyar Shadman, Michael LeBlanc, Lisa Rimsza, et al.
Hemasphere
|
December 26, 2022
COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Mazyar Shadman, Catherine Liu, Katherine Eakle, et al.
Leukemia & Lymphoma
|
July 26, 2016
Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience
Mazyar Shadman, Sangeeta Hingorani, Scott A Lanum, et al.
Page
of 23